Literature DB >> 14566623

Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease.

Vincenzo Parisi1.   

Abstract

In this article the correlations between the morphological evaluation of the nerve fiber layer (NFL) thickness (by OCT) and retinal functional assessment (by Pattern ERG recordings) performed in patients affected by ocular hypertension (OHT), glaucoma (OAG), demyelinating optic neuritis (MSON), and Alzheimer's disease (AD) are reported. In OHT eyes with ocular hypertension we observed that the inter-individual variation in NFL thickness is correlated with the variability of the PERG responses (the thinner the layer, the worse the visual function). In our OAG, MSON and AD eyes we observed a significant reduction in NFL thickness when compared with controls. In OHT, OAG, MSON and AD eyes abnormal PERG responses with delayed implicit times and reduced amplitudes were found. The impairment in the PERG parameters was significantly correlated to the reduction in NFL thickness. Our results suggest that in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis, and Alzheimer's Disease there is a reduction of NFL thickness evaluated "in vivo" by OCT, and this morphological involvement is correlated with electrophysiological responses assumed to be originating from the innermost retinal layers.

Entities:  

Mesh:

Year:  2003        PMID: 14566623     DOI: 10.1076/soph.18.2.50.15855

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  43 in total

1.  Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.

Authors:  C Bowd; A Tafreshi; L M Zangwill; F A Medeiros; P A Sample; R N Weinreb
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 3.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

4.  Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry.

Authors:  Kenzo Hokazono; Ali S Raza; Maria K Oyamada; Donald C Hood; Mário L R Monteiro
Journal:  Doc Ophthalmol       Date:  2013-07-30       Impact factor: 2.379

Review 5.  Glaucoma medications: use and safety in the elderly population.

Authors:  Elliott Kanner; James C Tsai
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study.

Authors:  Francisco J Ascaso; Nancy Cruz; Pedro J Modrego; Raul Lopez-Anton; Javier Santabárbara; Luis F Pascual; Antonio Lobo; José A Cristóbal
Journal:  J Neurol       Date:  2014-05-21       Impact factor: 4.849

7.  Electroretinogram findings in unilateral optic neuritis.

Authors:  Clare L Fraser; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

Review 8.  Cochlin and glaucoma: a mini-review.

Authors:  Sanjoy K Bhattacharya; Neal S Peachey; John W Crabb
Journal:  Vis Neurosci       Date:  2005 Sep-Oct       Impact factor: 3.241

Review 9.  Cochlin in the eye: functional implications.

Authors:  Renata Picciani; Kavita Desai; Jasenka Guduric-Fuchs; Tiziana Cogliati; Cynthia C Morton; Sanjoy K Bhattacharya
Journal:  Prog Retin Eye Res       Date:  2007-06-22       Impact factor: 21.198

10.  Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessments.

Authors:  Mitra Sehi; Mariana Pinzon-Plazas; William J Feuer; David S Greenfield
Journal:  J Glaucoma       Date:  2009 Oct-Nov       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.